Wairimu Njuki
Dr. Wairimu Njuki is the president of the Pharmaceutical Society of Kenya (PSK), where she advocates for policies that enhance local pharmaceutical manufacturing, attract investments, and improve access to quality medicines. She emphasizes the importance of Kenya's journey towards achieving the WHO's Maturity Level 3 status, viewing it as a commitment to ensuring the safety and efficacy of health products for citizens.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Kenya | 2 | 7.00 | 0.15% | +10% | 53,771,296 | 91,278 | $106,000 | 180$ |
| Totals | 2 | 53,771,296 | 91,278 | $106,000 | 180$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Kenya:
PSK president Dr Wairimu Njuki said Kenya possesses significant potential to expand local pharmaceutical manufacturing.
7
Kenya:
PSK president Dr Wairimu Njuki said Kenya possesses significant potential to expand local pharmaceutical manufacturing but requires a supportive environment that enables firms to grow and remain competitive.
7
Kenya:
PSK president Dr Wairimu Njuki said Kenya possesses significant potential to expand local pharmaceutical manufacturing.
7
Kenya:
Wairimu Njuki is the president of the Pharmaceutical Society of Kenya who emphasized the need for a supportive environment for local pharmaceutical manufacturing.
8